Anti-influenza drug screening and inhibition of apigetrin on influenza A virus replication via TLR4 and autophagy pathways.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 21 06 2023
revised: 29 08 2023
accepted: 12 09 2023
medline: 1 11 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

Activation of Toll-like receptor (TLR) 4 plays important roles in the influenzaA virus (IAV) infection. To explore TLR4 inhibitors, 161 traditional Chinese medicines (TCMs) were screened. Further, we screened out Ixeris sonchifolia Hance, and its active compound, Apigetrin (apigenin-7-O-glucoside). Antiviral activity of Apigetrin was determined by plaque assay. We also further investigated the influence of Apigetrin on immune signaling pathways including TLRs, MAPK, NF-κB and autophagy pathways. The in-vitro results showed that the extract and its several ingredients could significantly inhibit IAV replication. Apigetrin significantly improved IAV-induced oxidative stress, inhibited the IAV-induced cytokine storm by suppressing the excessive activation of TLR3/4/7, JNK/p38 MAPK and NF-κB. Apigetrin decreased autophagosome accumulation and promoted degradation of IAV protein. Interestingly, Apigetrin antiviral activity was reversed by using H

Identifiants

pubmed: 37804654
pii: S1567-5769(23)01268-7
doi: 10.1016/j.intimp.2023.110943
pii:
doi:

Substances chimiques

NF-kappa B 0
apigetrin 7OF2S66PCH
Apigenin 7V515PI7F6
Toll-Like Receptor 4 0
Hydrogen Peroxide BBX060AN9V
Antiviral Agents 0
TLR4 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110943

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Miao He (M)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China; College of Pharmacy, Dali University, Dali 671000, Yunnan, China; School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.

Zhihui Ren (Z)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China; Department of Anesthesiology, The Second Xiangya Hospital,Central South University. Changsha 410011, Hunan Province, China.

Mohsan Ullah Goraya (MU)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China; Institute of Microbiology, University of Agriculture Faisalabad, 38040, Pakistan.

Yinhong Lin (Y)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China.

Jinghan Ye (J)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China.

Rui Li (R)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China.

Jianping Dai (J)

Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515041, China. Electronic address: daijpedu2008@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH